Research and Markets has announced the addition of the "Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2016" report to their offering.

The report provides comprehensive information on the Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Additionally, the report provides an overview of key players involved in Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) targeted therapeutics development and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Respiratory Syncytial Virus Attachment Glycoprotein Overview
  3. Therapeutics Development
  4. Pipeline Products for Respiratory Syncytial Virus Attachment Glycoprotein - Overview
  5. Pipeline Products for Respiratory Syncytial Virus Attachment Glycoprotein - Comparative Analysis
  6. Respiratory Syncytial Virus Attachment Glycoprotein - Therapeutics under Development by Companies
  7. Respiratory Syncytial Virus Attachment Glycoprotein - Therapeutics under Investigation by Universities/Institutes
  8. Respiratory Syncytial Virus Attachment Glycoprotein Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Respiratory Syncytial Virus Attachment Glycoprotein - Products under Development by Companies
  13. Respiratory Syncytial Virus Attachment Glycoprotein - Products under Investigation by Universities/Institutes
  14. Respiratory Syncytial Virus Attachment Glycoprotein - Companies Involved in Therapeutics Development

- Agilvax Inc

- Bavarian Nordic A/S

- Emergent BioSolutions Inc

- F. Hoffmann-La Roche Ltd

- Trellis Bioscience Inc

- Visterra Inc

For more information about this report visit http://www.researchandmarkets.com/research/vp55rs/respiratory